retatrutide phase 3 trial The numbers from Lilly's dropped this week and I haven't been able to stop thinking about them. Not only as a doctor but as a long-term GLP-1 user Retatrutide Shows 28.3% Weight Loss

Insurance companies are more likely to cover medications for their intended use, making the switch to a prescribed weight loss option not just medically sound but also potentially more economical

Out-of-Pocket Costs When Insurance Denies Coverage When insurance declines to pay for GLP-1 therapy, patients typically face retail pharmacy prices of $900 to $1,500 per month for brand-name medications

This peptide therapy for fat loss improves insulin sensitivity and glucose regulation, supports weight management by enhancing fat and energy metabolism Boosts exercise capacity and endurance May reduce fatigue and improve recovery Provides antioxidant effects, reducing oxidative stress Promotes healthy aging by supporting mitochondrial health May protect against age-related decline in metabolic function Preclinical evidence suggests neuroprotective effects May help with stress adaptation and mental clarity Survodutide is a dual-action peptide designed to regulate appetite and enhance metabolic function, making it a highly effective peptide for weight management and fat reduction

Once you understand how to use the medication correctly, it will become second nature